Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 8 (1), 4
- https://doi.org/10.1186/1475-2840-8-4
Abstract
Poor control of blood glucose in diabetes is known to promote vascular dysfunction and hypertension. Diabetes was recently shown to be linked to an increased prevalence of pulmonary hypertension. The aim of this study was to determine how the pharmacological reactivity of intrapulmonary arteries is altered in a rat model of diabetes.Keywords
This publication has 36 references indexed in Scilit:
- Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase inductionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Pulmonary hypertension: therapeutic targets within the serotonin systemBritish Journal of Pharmacology, 2008
- Simvastatin Improves Diabetes-Induced Coronary Endothelial DysfunctionJournal of Pharmacology and Experimental Therapeutics, 2006
- Overexpression of the 5-Hydroxytryptamine Transporter GeneCirculation, 2004
- Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levelsJournal of the American College of Cardiology, 1996
- Platelet serotonin transport is altered in streptozotocin-induced diabetic ratsLife Sciences, 1995
- Increased vasodilator response to acetylcholine of renal blood vessels from diabetic ratsJournal of Pharmacy and Pharmacology, 1988
- Modulation of vascular tonus by the endothelium in experimental diabetesLife Sciences, 1987
- Lipids in the pulmonary artery and the lungs of severely diabetic ratsDiabetologia, 1977
- Diabetogenic action of streptozotocin: relationship of dose to metabolic responseJournal of Clinical Investigation, 1969